Pages that link to "Q36996728"
Jump to navigation
Jump to search
The following pages link to New and emerging combination therapies for esophageal cancer (Q36996728):
Displaying 9 items.
- "Targeted" Chemotherapy for Esophageal Cancer (Q37734452) (← links)
- Cetuximab in patients with esophageal cancer: a systematic review and meta-analysis of randomized controlled trials. (Q38385570) (← links)
- The clinical utility of RFA in esophageal and cardia cancer patients with severe malignant obstruction (Q39184664) (← links)
- Neoadjuvant Therapy for Esophageal Adenocarcinoma in the Community Setting-Practice and Outcomes (Q41037588) (← links)
- TP53, PIK3CA, FBXW7 and KRAS Mutations in Esophageal Cancer Identified by Targeted Sequencing. (Q46036182) (← links)
- Prognostic role of initial pan-endoscopic tumor length at diagnosis in operable esophageal squamous cell carcinoma undergoing esophagectomy with or without neoadjuvant concurrent chemoradiotherapy (Q47296527) (← links)
- Liposomal Co-Delivery of Omacetaxine Mepesuccinate and Doxorubicin for Synergistic Potentiation of Antitumor Activity (Q58759678) (← links)
- In vitro screening of cytotoxic activity of euphol from Euphorbia tirucalli on a large panel of human cancer-derived cell lines (Q63405978) (← links)
- Immune checkpoint inhibitors in esophageal squamous cell carcinoma: progress and opportunities (Q90263373) (← links)